Huntington National Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18K Buy
627
+78
+14% +$2.24K ﹤0.01% 1610
2025
Q1
$18.4K Buy
549
+54
+11% +$1.81K ﹤0.01% 1545
2024
Q4
$25.3K Sell
495
-66
-12% -$3.38K ﹤0.01% 1468
2024
Q3
$28.7K Sell
561
-19
-3% -$971 ﹤0.01% 1398
2024
Q2
$26K Sell
580
-3
-0.5% -$134 ﹤0.01% 1378
2024
Q1
$27.3K Sell
583
-266
-31% -$12.5K ﹤0.01% 1364
2023
Q4
$30.2K Sell
849
-19
-2% -$676 ﹤0.01% 1286
2023
Q3
$25.8K Sell
868
-325
-27% -$9.67K ﹤0.01% 1271
2023
Q2
$21.5K Buy
1,193
+344
+41% +$6.2K ﹤0.01% 1338
2023
Q1
$13.6K Buy
+849
New +$13.6K ﹤0.01% 1445